منابع مشابه
Conflict of Interest Statement. the Weight Management Programme Was Established with Unrestricted Educational Grants from Roche Reply—orlistat and Renal Failure Letters
Sir, We welcome the interest of MacLaughlin and Macdougall in the use of the gastrointestinal lipase inhibitor orlistat in patients with chronic kidney disease (CKD). We previously reported the rapid, non-recoverable decline of renal function in a patient with diabetic nephropathy, that coincided temporally with the successful use of orlistat for weight reduction [1]. There was histological evi...
متن کاملChronic Renal Failure and Its effects on Serum Lipids
Background: Metabolic disturbances and dyslipidemia are among the most important medical problems in human society. Their effects on the mortality of coronary heart disease (CHD) have lead to many investigations about them. Materials and Methods: An epidemiologic cross-sectional study was carried out on 10136 persons selected randomly in Tehran urban district 13 with a minimum age of 20 years ...
متن کاملAssociation of hemodialysis and pruritus in chronic renal failure
Background and aim: Pruritus is a common disabling problem in patients with end stage renal disease. Several studies has recorded the relation between pruritus with hemodialysis in chronic renal failure (CRF) patients. This study was designed to evaluate the effect of hemodialysis on pruritus of patients with CRF.Materials and Methods: After recording the demographic data and the diagnosis of d...
متن کاملEtiology of Chronic Renal Failure in Children and Lnfants
Chronic renal failure is an uncommon disease in children with some difference in the etiology in different countries. In this study on 180 children (From 1987 to 1997 in Shiraz) with age range of 3 months to 15 years (mean 8.6±4.2 years). The male to female ratio was 1. 57: 1. The etiology of chronic renal failure in decreasing order of frequency were: reflux nephropathy (25 % ) , glbmerular di...
متن کاملOrlistat, an under-recognised cause of progressive renal impairment.
Obesity is an emerging risk factor for chronic kidney disease (CKD) in the developed world. Orlistat, an intestinal lipase inhibitor, used in the treatment of obesity is available as an over-the-counter medication across the European union and in many countries worldwide. It is associated with acute kidney injury (AKI). We present three adults, followed up from 1 to 6 years, who developed de no...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2007
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gfm211